Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Sonntag, 12.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

PFIZER INC

WKN: 852009  ISIN: US7170811035  Ticker-Symbol: PFE 
Branche
Pharma
Aktienmarkt
DJ Industrial
S&P 100
S&P 500
1-Jahres-Chart
PFIZER INC Chart 1 Jahr
1-Woche-Intraday-Chart
PFIZER INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
Taxe
15,910
16,010
18:52
Passende RBS Produkte (Anzeige)Schnell, effizient und fair traden: marketindex-Handelsplattform!
AnzahlProdukttyp AnzahlProdukttyp AnzahlProdukttyp
12
Bonus Zertifikate
7
MINI Long
19
Discount Zertifikate

Aktuelle News zur PFIZER Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
14:314
11.02. 1
10.02. 108
Headline of release should read: Branham Law Group Investigates Pfizer for Packaging Error Recall (sted Branham Law Group Investigates Pfizer for Qualitest Packaging Error...
Mehr lesen zu:
CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall
10.02. 4
09.02. -
09.02. 94
Branham Law Group, LLP, a Dallas, Texas law firm, is investigating Pfizer (NYSE: PFE) for its recall of 14 lots of Lo/Ovral-28 tablet packs and 14 lots of generic...
Mehr lesen zu:
Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall
09.02. 4
09.02. 31
CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer
09.02. 5
08.02. 79
Biologics, Inc., an integrated oncology services company has been selected as a Limited Distribution Network (LDN) partner for Pfizer's Inlyta which was approved by the...
Mehr lesen zu:
Pfizer Selects Biologics, Inc. as Limited Distribution Network Partner (LDN)
08.02. 52
The COPD Drug Market Will Increase from Approximately $8 Billion in 2010 to $13 Billion in 2020, According to Findings from Decision Resources ...
Mehr lesen zu:
Boehringer Ingelheim/Pfizer's Spiriva Has Earned Decision Resources' Proprietary Clinical Gold Standard Status for the Treatment of Chronic Obstructive Pulmonary Disease
08.02. 36
NEW YORK, NY -- (Marketwire) -- 02/08/12 -- With the S&P 500 skyrocketing in the early stages of 2012, investors are shifting away from dividend-paying stocks. According to a recent article from The...
Mehr lesen zu:
Blue Chip Dividend Plays Losing Appeal in 2012 / The Paragon Report Provides Equity Research on 3M and Pfizer
08.02. 21
07.02. 61
CHICAGO, Feb. 7, 2012 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca
07.02. 8
07.02. 18
07.02. 17
07.02. 14
07.02. 7
06.02. 14
Seite: 1 2 3 4 5 ... Weiter>>
522 Nachrichten in den letzten 6 Monaten